{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:30:33Z","timestamp":1785256233940,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"am","delay-in-days":295,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["PTCB08_05"],"award-info":[{"award-number":["PTCB08_05"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["ID 1011626"],"award-info":[{"award-number":["ID 1011626"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1102604"],"award-info":[{"award-number":["APP1102604"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.canep.2021.102036","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T22:35:57Z","timestamp":1632350157000},"page":"102036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Analgesic use and the risk of renal cell carcinoma \u2013 Findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) study"],"prefix":"10.1016","volume":"75","author":[{"given":"F.J.","family":"Bruinsma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.K.","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Severi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"MacInnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jefford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.D.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Dudding-Byth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"English","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.G.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Winship","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2021.102036_bib1","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Disease Prim."},{"key":"10.1016\/j.canep.2021.102036_bib2","first-page":"1","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and motality worldwide for 36 cancers in 185 countries","volume":"0","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canep.2021.102036_bib3","unstructured":"Australian Institute of Health and Welfare , Cancer in Australia 2017. AIHW, 2017."},{"key":"10.1016\/j.canep.2021.102036_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00008469-200204000-00010","article-title":"Global increases in kidney cancer incidence, 1973-1992","volume":"11","author":"Mathew","year":"2002","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.canep.2021.102036_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/pds.3463","article-title":"Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population","volume":"23","author":"Zhou","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.canep.2021.102036_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40360-015-0028-7","article-title":"Prevalence, trends, patterns and associations of analgesic use in Germany","volume":"16","author":"Saraganas","year":"2015","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.canep.2021.102036_bib7","series-title":"Australian Statistics on Medicine 2015","author":"Mabbot","year":"2016"},{"key":"10.1016\/j.canep.2021.102036_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0002-9343(83)90235-8","article-title":"Renal effects of antipyretic analgesics","volume":"75","author":"Singh Nanra","year":"1983","journal-title":"Am. J. Med."},{"key":"10.1016\/j.canep.2021.102036_bib9","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1073\/pnas.091057698","article-title":"Direct toxicity of nonsteroidal antiinflammatory drugs for renal medullary cells","volume":"98","author":"Rocha","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canep.2021.102036_bib10","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2215\/CJN.14331218","article-title":"Risk of nephrotic syndrome for non-steroidal anti-inflammatory drug users","volume":"14","author":"Bakhriansyah","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.canep.2021.102036_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bcp.14141","article-title":"Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors","volume":"86","author":"Mark","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"280","key":"10.1016\/j.canep.2021.102036_bib12","first-page":"e1","article-title":"NSAID use and progression of chronic kidney disease","volume":"120","author":"Gooch","year":"2007","journal-title":"Am. J. Med."},{"key":"10.1016\/j.canep.2021.102036_bib13","unstructured":"IARC . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Phenacetin 2012;100A."},{"key":"10.1016\/j.canep.2021.102036_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ki.1978.10","article-title":"Analgesic abuse and renal failure in Australasia","volume":"13","author":"Stewart","year":"1978","journal-title":"Kidney Int."},{"key":"10.1016\/j.canep.2021.102036_bib15","first-page":"134","article-title":"Is phenacetin responsible for analgesic nephropathy in New South Wales?","volume":"17","author":"McCredie","year":"1982","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.canep.2021.102036_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ijc.2910530212","article-title":"Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis","volume":"53","author":"McCredie","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canep.2021.102036_bib17","first-page":"275","article-title":"A population-based case-control study of renal cell carcinoma","volume":"72","author":"McLaughlin","year":"1984","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canep.2021.102036_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/1753-6405.12252","article-title":"The ban on phenacetin is associated with changes in the incidence trends of upper urinary tract cancers in Australia","volume":"38","author":"Antoni","year":"2014","journal-title":"Aust. N.Z. J. Pub. Health"},{"key":"10.1016\/j.canep.2021.102036_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1464-410x.2000.00708.x","article-title":"Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention","volume":"86","author":"Dh\u00f4te","year":"2001","journal-title":"BJU Int."},{"key":"10.1016\/j.canep.2021.102036_bib20","first-page":"1865","article-title":"A large cohort study of nonsteroidal anti-inflammatory drugs and renal cell carcinoma incidence in the National Institutes of Health-AARP Diet and Health Study","volume":"24","author":"Liu","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canep.2021.102036_bib21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bjc.6690728","article-title":"Regular use of analgesics is a risk factor for renal cell carcinoma","volume":"81","author":"Gago-Dominguez","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canep.2021.102036_bib22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ijc.30108","article-title":"Analgesic use and risk of renal cell carcinoma: a case\u2010control, cohort and meta\u2010analytic assessment","volume":"139","author":"Karami","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canep.2021.102036_bib23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ijc.28093","article-title":"Analgesic use and the risk of kidney cancer: a meta\u2010analysis of epidemiologic studies","volume":"134","author":"Choueiri","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canep.2021.102036_bib24","unstructured":"Thursfield V., Staines C., Giles G., Farrugia H., Cancer in Victoria: Statistics & trends 2012. Cancer Council Victoria, 2013."},{"key":"10.1016\/j.canep.2021.102036_bib25","unstructured":"Queensland Cancer Registry , 1982\u20132011 - Incidence, survival, mortality and prevalence. Queensland Cancer Council, 2013."},{"key":"10.1016\/j.canep.2021.102036_bib26","first-page":"3195","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs)","volume":"346","author":"Day","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.canep.2021.102036_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147635","article-title":"Is long-term low-dose aspirin therapy associated with renal dysfunction in patients with type 2 diabetes? JPAD2 cohort study","volume":"11","author":"Okada","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.canep.2021.102036_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0002-9343(03)00436-4","article-title":"Early and late effects of low-dose aspirin on renal function in elderly patients","volume":"115","author":"Segal","year":"2003","journal-title":"Am. J. Med."},{"key":"10.1016\/j.canep.2021.102036_bib29","series-title":"Modern Epidemiology","author":"Rothman","year":"2008"},{"key":"10.1016\/j.canep.2021.102036_bib30","unstructured":"Australian Bureau of Statistics , National Health Survey: Use of Medication, Australia, 1995, 1999."},{"key":"10.1016\/j.canep.2021.102036_bib31","series-title":"National Health Survey: First Results, 2017-2018","year":"2018"},{"key":"10.1016\/j.canep.2021.102036_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/AJP.0000000000000248","article-title":"Accuracy of self-report prescribed analgesic medication use. Linkage between the quebec pain registry and the quebec administrative prescription claims databases","volume":"32","author":"Lacasse","year":"2016","journal-title":"Clin J Pain"},{"key":"10.1016\/j.canep.2021.102036_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/aje\/kwr292","article-title":"A comparison of self-reported analgesic use and detection of urinary ibuprofen and acetaminophen metabolites by means of metabonomics","volume":"175","author":"Loo","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canep.2021.102036_bib34","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/00001648-200111000-00018","article-title":"Acetaminophen and the risk of renal and bladder cancer in the general practice research database","volume":"12","author":"Kaye","year":"2001","journal-title":"Epidemiol"},{"key":"10.1016\/j.canep.2021.102036_bib35","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/sj.bjc.6600945","article-title":"Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study","volume":"88","author":"S\u00f8rensen","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canep.2021.102036_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ijc.2910590406","article-title":"Use of analgesics and risk of renal cell cancer","volume":"59","author":"Chow","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canep.2021.102036_bib37","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archinternmed.2011.356","article-title":"Prospective evaluation of analgesic use and risk of renal cell cancer","volume":"171","author":"Cho","year":"2011","journal-title":"Arch. Int. Med."},{"key":"10.1016\/j.canep.2021.102036_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.COT.0000482228.48342.79","article-title":"Beware of non-aspirin NSAIDs for kidney cancer patients","volume":"38","author":"Preston","year":"2016","journal-title":"Oncology Times"},{"key":"10.1016\/j.canep.2021.102036_bib39","first-page":"79","article-title":"Gender differences and pain medication","volume":"5","author":"Richardson","year":"2009","journal-title":"Women\u2019s Health"},{"key":"10.1016\/j.canep.2021.102036_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/ajpregu.00901.2005","article-title":"Sex differences in inflammation and inflammatory pain in cyclooxygenase-deficient mice","volume":"291","author":"Chillingworth","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.canep.2021.102036_bib41","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1038\/s41598-020-60053-y","article-title":"Gender-specific changes in energy metabolism and protein degradation as major pathways affected in livers of mice treated with ibuprofen","volume":"10","author":"Tiwari","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canep.2021.102036_bib42","first-page":"1254","article-title":"Sex-based differences in drug activity","volume":"80","author":"Whitley","year":"2009","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.canep.2021.102036_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.canep.2021.102036_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003088-200342020-00001","article-title":"The influence of sex on pharmocokinetics","volume":"42","author":"Schwartz","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.canep.2021.102036_bib45","first-page":"101","article-title":"Risk factors for renal cell carcinoma: results of a population-based case-control study","volume":"4","author":"Kreiger","year":"1993","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canep.2021.102036_bib46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ijc.2910600312","article-title":"International renal-cell cancer study. II","volume":"60","author":"McCredie","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canep.2021.102036_bib47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ije\/23.5.923","article-title":"Risk factors for renal cell carcinoma in Denmark: role of medication and medical history","volume":"23","author":"Mellemgaard","year":"1994","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.canep.2021.102036_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ijc.1581","article-title":"Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study","volume":"97","author":"Friis","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canep.2021.102036_bib49","first-page":"83","article-title":"Transitional cell cancer of the urinary tract and renal cell cancer in relation to acetaminophen use (United States)","volume":"9","author":"Rosenberg","year":"1998","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canep.2021.102036_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ijc.2910420104","article-title":"Risk factors for cancer of the renal parenchyma","volume":"42","author":"McCredie","year":"1988","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canep.2021.102036_bib51","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0895-4356(92)90118-7","article-title":"Risk of kidney cancer in analgesics users","volume":"45","author":"Mellemgaard","year":"1992","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.canep.2021.102036_bib52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/0100-3984.2013.1927","article-title":"Renal cell carcinoma: histological classification and correlation with imaging findings","volume":"48","author":"Muglia","year":"2015","journal-title":"Radiol. Bras."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782121001533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782121001533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:39:02Z","timestamp":1778830742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782121001533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":52,"alternative-id":["S1877782121001533"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2021.102036","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analgesic use and the risk of renal cell carcinoma \u2013 Findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) study","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2021.102036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102036"}}